EUVIMEDEUVIMED entdecken
Crossref

Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway

Zilin Wang, Ya Zhang, Yinghui Wang, Qiuju Mou, Tingting Ren, Lili Zhu

Journal of Biochemical and Molecular Toxicology · 2023

DOI: 10.1002/jbt.23338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Zilin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: NF-kappa B, Transforming Growth Factor beta1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Qian ke he platform talents, Training Program of the National Natural Science Foundation of Affiliated Hospital of Guizhou Medical University, Doctoral Fund of Affliated Hospital of Guizhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis is a grievous global challenge, where hepatic stellate cells (HSCs) activation is a paramount step. This study analyzed the mechanism of Tβ4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway. The liver fibrosis mouse models were established via bile duct ligation (BDL) and verified by HE and Masson staining. TGF‐β1‐induced activated LX‐2 cells were employed in vitro experiments. Tβ4 expression was determined using RT‐qPCR, HSC activation markers were examined using Western blot analysis, and ROS levels were tested via DCFH‐DA kits. Cell proliferation, cycle, and migration were examined by CCK‐8, flow cytometry, and Transwell assays, respectively. Effects of Tβ4 on liver fibrosis, HSC activation, ROS production, and HSC growth were analyzed after transfection of constructed Tβ4‐overexpressing lentiviral vectors. MAPK/NF‐κB‐related protein levels were tested using Western blotting and p65 expression in the nucleus was detected through immunofluorescence. Regulation of MAPK/NF‐κB pathway in TGF‐β1‐induced LX‐2 cells was explored by adding MAPK activator U‐46619 or inhibitor SB203580. Furthermore, its regulating in liver fibrosis was verified by treating BDL mice overexpressing Tβ4 with MAPK inhibitor or activator. Tβ4 was downregulated in BDL mice. Tβ4 overexpression inhibited liver fibrosis. In TGF‐β1‐induced fibrotic LX‐2 cells, Tβ4 was reduced and cell migration and proliferation were enhanced with elevated ROS levels, while Tβ4 overexpression suppressed cell migration and proliferation. Tβ4 overexpression blocked the MAPK/NF‐κB pathway activation by reducing ROS production, thus inhibiting liver fibrosis in TGF‐β1 induced LX‐2 cells and BDL mice. Tβ4 ameliorates liver fibrosis by impeding the MAPK/NF‐κB pathway activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BTransforming Growth Factor beta1AnimalsMiceHepatic Stellate CellsLiverLiver CirrhosisReactive Oxygen SpeciesThymosin beta(4)

Stichwörter der Autor:innen

MAPKNF-κBTGF-β1Thymosin β4bile duct ligationhepatic stellate cellsliver fibrosisreactive oxygen species

Substanzen

NF-kappa BReactive Oxygen SpeciesTransforming Growth Factor beta1Thymosin beta(4)Tmsb4x protein, mouse

Autor:innen und Institutionen

  • Department of Blood Transfusion, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Clinical Hematology, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Medical Laboratory, Guizhou Qiannan Pepole's Hospital, Duyun, Guizhou, China.
  • Department of Clinical Laboratory, Guiyang Public Health Clinical Center, Guiyang, Guizhou, China.

Förderung

  • Qian ke he platform talents
  • Training Program of the National Natural Science Foundation of Affiliated Hospital of Guizhou Medical University
  • Doctoral Fund of Affliated Hospital of Guizhou Medical University
  • Training Program of the National Natural Science Foundation of Guizhou Medical University
  • Doctoral Fund of Affiliated Hospital of Guizhou Medical University

Zitieren

APA

Wang, Z., Zhang, Y., Wang, Y., Mou, Q., Ren, T., & Zhu, L. (2023). Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23338

Vancouver

Wang Z, Zhang Y, Wang Y, Mou Q, Ren T, Zhu L. Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23338

BibTeX
@article{Wang2023,
  author = {Wang, Zilin and Zhang, Ya and Wang, Yinghui and Mou, Qiuju and Ren, Tingting and Zhu, Lili},
  title = {Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2023},
  doi = {10.1002/jbt.23338}
}
Kostenlos starten →